In the STEP-1 trial of 1,961 adults (Wilding and colleagues, Once-Weekly Semaglutide in Adults with Overweight or Obesity, New England Journal of Medicine, 2021), participants on semaglutide 2.4 mg lost an average of 14.9 percent of their body weight at 68 weeks, compared to 2.4 percent on placebo
How to calculate your Synedica Retatrutide dosage Synedica Retatrutide is administered as a once-weekly subcutaneous injection following the gradual escalation schedule from Phase 3 clinical trials: Weeks 14: 2mg once weekly Weeks 58: 4mg once weekly Weeks 912: 8mg once weekly Week 13 onward: 9mg or 12mg once weekly (maintenance) The 12mg maintenance dose consistently produces the highest Synedica Retatrutide weight loss results across all clinical data published to date
Appetite Suppression Enhanced Fat Metabolism Increased Energy Levels Achieve Lasting Results with Retatrutide How Does Retatrutide Work
For the complete FDA timeline, trial enrollment steps, and legal access pathways, see our how to get retatrutide guide
Within two days, Ro ran my prior authorization and guided me to a savings card
Thats the biggest increase in a decade